Women's Health Events
From the FDA Office of Women's Health
FDA’s Office of Women’s Health (OWH) is pleased to present a series of educational webinars on a broad range of topics to promote, protect, and advance the health of women. These webinars target the needs of researchers, healthcare professionals, and students. Watch this space for new events in 2025!
Previous events
Sickle Cell Disease: A Spotlight on Women
This webinar discussed the clinical characteristics of sickle cell disease (SCD), advances in medical therapies to treat SCD, and the unique factors impacting women living with SCD.
PCOS Revisited: Diagnosis, Management, and Future Needs
This webinar reviewed the pathophysiology, diagnosis, comorbidities, and findings from recent research on Polycystic Ovary Syndrome.
Menopause: Potential Impact on Clinical Pharmacology
Speakers discussed the current understanding of the impact of menopause on the pharmacokinetics and pharmacodynamics, and exposure-response relationships of FDA-regulated drugs and biologics used by menopausal women for non-menopause-related indications
Osteoporosis: A Perspective for 2024
The lecture summarized the current approach to assessing bone health, as well as preventing and treating osteoporosis with a focus on postmenopausal women.
More previous events
OWH offers recordings of previous events on a variety of women’s health topics, including CE for health professionals for some events.
OWH continuing education (CE)
OWH offers recordings of previous events for continuing education credit.